title: Rituximab monotherapy for patients with recurrent primary CNS lymphoma.
authors.affiliation: Stephen E. and Catherine Pappas Center for Neuro-Oncology, Yawkey 9E, Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA 02114, USA. tbatchelor@partners.org
authors.forename: T T
authors.initials: TT
authors.lastname: Batchelor
authors.forename: S A
authors.initials: SA
authors.lastname: Grossman
authors.forename: T
authors.initials: T
authors.lastname: Mikkelsen
authors.forename: X
authors.initials: X
authors.lastname: Ye
authors.forename: S
authors.initials: S
authors.lastname: Desideri
authors.forename: G J
authors.initials: GJ
authors.lastname: Lesser
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016543:Central Nervous System Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D017567:Karnofsky Performance Status; D008223:Lymphoma / Q000188:drug therapy*; D008297:Male; D008609:Mental Status Schedule; D008875:Middle Aged; D016017:Odds Ratio; D010865:Pilot Projects; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab